EP1753725 - TETRAHYDROISOQUINOLINE SULFONAMIDE DERIVATIVES, THE PREPARATION THEREOF, AND THE USE OF THE SAME IN THERAPEUTICS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.01.2014 Database last updated on 19.10.2024 | Most recent event Tooltip | 24.01.2014 | Change - lapse in a contracting state State(s) deleted from list of lapses: CY | published on 26.02.2014 [2014/09] | Applicant(s) | For all designated states SANOFI 54, rue La Boétie 75008 Paris / FR | [2013/09] |
Former [2012/18] | For all designated states SANOFI 54 rue La Boétie 75008 Paris / FR | ||
Former [2012/17] | For all designated states SANOFI 54, rue de la Boétie 75008 Paris / FR | ||
Former [2011/30] | For all designated states SANOFI 174, Avenue de France 75013 Paris / FR | ||
Former [2007/08] | For all designated states Sanofi-Aventis 174, Avenue de France 75013 Paris / FR | Inventor(s) | 01 /
DIAZ MARTIN, Juan Antonio C/Colombia, 30-5[deg] izda E-28016 Madrid / ES | 02 /
JIMENEZ BARGUENO, Maria Dolores Paseo de la Chopera n[deg] 102 E-28100 Alcobendas / ES | [2007/08] | Representative(s) | Kugel, Dominique, et al Sanofi Département Brevets 54, rue La Boétie 75008 Paris / FR | [N/P] |
Former [2013/09] | Kugel, Dominique, et al Sanofi-Aventis Département Brevets 174 Avenue de France 75013 Paris / FR | ||
Former [2009/38] | Kugel, Dominique, et al Sanofi-Aventis Département Brevets 174 Avenue de France 75013 Paris / FR | ||
Former [2007/08] | Kugel, Dominique, et al Sanofi-Aventis, Patent Department, 174 avenue de France 75013 Paris / FR | Application number, filing date | 05772938.6 | 24.05.2005 | [2007/08] | WO2005FR01279 | Priority number, date | FR20040005607 | 25.05.2004 Original published format: FR 0405607 | [2007/08] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO2005118547 | Date: | 15.12.2005 | Language: | FR | [2005/50] | Type: | A1 Application with search report | No.: | EP1753725 | Date: | 21.02.2007 | Language: | FR | The application published by WIPO in one of the EPO official languages on 15.12.2005 takes the place of the publication of the European patent application. | [2007/08] | Type: | B1 Patent specification | No.: | EP1753725 | Date: | 27.02.2013 | Language: | FR | [2013/09] | Search report(s) | International search report - published on: | EP | 15.12.2005 | Classification | IPC: | C07D217/02, C07D217/04, C07D217/06, C07D401/12, C07D405/06, C07D409/06, A61K31/4725, A61K31/472, A61K31/496, A61K31/5377, A61P3/04, A61P3/10, A61P25/00 | [2007/08] | CPC: |
C07D405/06 (EP,KR,US);
C07D217/02 (EP,NO,US);
C07D217/04 (EP,KR,NO,US);
A61K31/472 (NO);
A61K31/4725 (NO);
A61P1/08 (EP);
A61P15/00 (EP);
A61P15/10 (EP);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
C07D217/06 (EP,KR,NO,US);
C07D401/12 (EP,KR,NO,US);
C07D409/06 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/08] | Extension states | AL | 27.12.2006 | BA | 27.12.2006 | HR | 27.12.2006 | LV | 27.12.2006 | MK | 27.12.2006 | YU | 27.12.2006 | Title | German: | TETRAHYDROISOCHINOLINSULFONAMID-DERIVATE, DEREN HERSTELLUNG UND THERAPEUTISCHE VERWENDUNG | [2007/08] | English: | TETRAHYDROISOQUINOLINE SULFONAMIDE DERIVATIVES, THE PREPARATION THEREOF, AND THE USE OF THE SAME IN THERAPEUTICS | [2007/08] | French: | DERIVES DE TETRAHYDROISOQUINOLILSULFONAMIDES, LEUR PREPARATION ET LEUR UTILISATION EN THERAPEUTIQUE | [2007/08] | Entry into regional phase | 27.12.2006 | National basic fee paid | 27.12.2006 | Designation fee(s) paid | 27.12.2006 | Examination fee paid | Examination procedure | 23.03.2006 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 27.12.2006 | Examination requested [2007/08] | 20.11.2009 | Despatch of a communication from the examining division (Time limit: M04) | 08.02.2010 | Reply to a communication from the examining division | 24.09.2012 | Communication of intention to grant the patent | 16.01.2013 | Fee for grant paid | 16.01.2013 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.11.2009 | Opposition(s) | 28.11.2013 | No opposition filed within time limit [2014/06] | Fees paid | Renewal fee | 14.05.2007 | Renewal fee patent year 03 | 28.03.2008 | Renewal fee patent year 04 | 02.06.2009 | Renewal fee patent year 05 | 31.03.2010 | Renewal fee patent year 06 | 11.05.2011 | Renewal fee patent year 07 | 12.03.2012 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 27.02.2013 | [2014/09] |
Former [2014/03] | CY | 27.02.2013 | |
MC | 27.02.2013 | ||
Former [2013/52] | CY | 27.02.2013 | Cited in | International search | [Y]WO02076925 (LILLY CO ELI [US], et al) [Y] 1-8* page 1, lignes 19-22; composé 250; tableau 2; revendications 1,5,7,12-15,21,22 *; | [X]WO03055848 (BAYER AG [DE], et al) [X] 1,2,5,6 * composé intermediaire [IV] à la page 15 combiné avec les définitions de R4/R5 de l'exemple 87; page 30; revendication 1 *; | [XY]WO2004019935 (BOEHRINGER INGELHEIM PHARMA [US]) [X] 5 * 5ème composé à la page 100; revendications 1,14,17,20,23 * [Y] 1-8 | by applicant | WO02076925 | WO03055848 | WO2004019935 |